scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026327233 |
P356 | DOI | 10.1245/S10434-009-0536-Z |
P698 | PubMed publication ID | 19641972 |
P2093 | author name string | Joerg O W Pelz | |
David L Morris | |||
Alexander Kerscher | |||
Jesus Esquivel | |||
Terence C Chua | |||
P2860 | cites work | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology | Q33262026 |
Primary signet-ring cell carcinoma of the colorectum | Q43495293 | ||
P433 | issue | 10 | |
P921 | main subject | peritoneal carcinomatosis | Q2071182 |
P304 | page(s) | 2765-2770 | |
P577 | publication date | 2009-07-30 | |
P1433 | published in | Annals of Surgical Oncology | Q2853069 |
P1476 | title | Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma | |
P478 | volume | 16 |
Q48224807 | Adenocarcinoma Ex-goblet Cell Carcinoid of the Appendix: a Case Report and Overview of the Disease |
Q46023282 | Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer. |
Q40013737 | Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma. |
Q36758925 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours |
Q55406271 | Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis. |
Q26768309 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality |
Q41547533 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence |
Q33418610 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis |
Q44892132 | Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin |
Q41972060 | Metastatic signet ring cell carcinoma of unknown primary source |
Q26774607 | Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases |
Q39442876 | Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer |
Q37504169 | Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm? |
Q47331073 | Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis |
Q60948065 | Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer |
Q35285305 | Update on the role of imaging in management of metastatic colorectal cancer |
Search more.